The 5-year survival rate was 57% for tumor stage III cases with high CLIC1 expression compared to a 72% 5-year survival rate in the case of low expressing patients from similar tumor stages (III) (p = 0.031; Figure 7b). This evidence concerns the gene CLIC1 and neoplasm.